Taofeek K Owonikoko (@teekayowo) 's Twitter Profile
Taofeek K Owonikoko

@teekayowo

Director @UMGCCC Greenebaum Professor of Oncology, Snr Assoc Dean @UMmedicine; Assoc Vice President @UMBaltimore. @ASCO Board Member 2021-2024, Opinions=my own

ID: 105602612

linkhttps://dom.pitt.edu/dr-taofeek-owonikoko-named-chief-of-the-division-of-hematology-oncology/ calendar_today16-01-2010 21:56:06

698 Tweet

2,2K Followers

282 Following

UMGCCC (@umgccc) 's Twitter Profile Photo

Yesterday, Dr. Owonikoko Taofeek K Owonikoko, Executive Director of UMGCCC, & Dr. Mark Gladwin, Dean of @UmMedSchool, shared breakthroughs in cancer & sickle cell disease at the 2nd Annual Scientific Symposium at the Institute of Human Virology Nigeria IHVN IRCE. alutanews.ng/2024/08/14/ihv…

Yesterday, Dr. Owonikoko <a href="/teekayowo/">Taofeek K Owonikoko</a>, Executive Director of UMGCCC, &amp; Dr. Mark Gladwin, Dean of @UmMedSchool, shared breakthroughs in cancer &amp; sickle cell disease at the 2nd Annual Scientific Symposium at the Institute of Human Virology Nigeria <a href="/irce_ihvn/">IHVN IRCE</a>.
alutanews.ng/2024/08/14/ihv…
Taofeek K Owonikoko (@teekayowo) 's Twitter Profile Photo

Impressive accomplishments by UMB public health scientists at the Institute of Human Virology Nigeria leading the national strategy for HIV control over the past 2 decades. Poised for expanded scope to SCD and cancer in Nigeria University of Maryland School of Medicine University of Maryland Medical Center University of Maryland, Baltimore UMMS Foundation

Taofeek K Owonikoko (@teekayowo) 's Twitter Profile Photo

We look forward to welcoming @FertigLab to UMGCCC and building a stronger, better future together for our patients and communities across Maryland. Time to exploit and expand the intersection of genome science and cancer University of Maryland, Baltimore University of Maryland Medical System University of Maryland School of Medicine

UMGCCC (@umgccc) 's Twitter Profile Photo

The cover of Cancer Epidemiology, Biomarkers & Prevention features a graphic adapted from a new study by Kathryn Hughes Barry linking neighborhood disadvantage, racial segregation and historical redlining with increased risk of aggressive prostate cancer, particularly in African-American men. umms.com/3BMOm76

The cover of <a href="/CEBP_AACR/">Cancer Epidemiology, Biomarkers & Prevention</a> features a graphic adapted from a new study by <a href="/kathrynhbarry1/">Kathryn Hughes Barry</a> linking neighborhood disadvantage, racial segregation and   historical redlining with increased risk of aggressive prostate cancer, particularly in African-American men. umms.com/3BMOm76
Kelly Mercier, Ph.D (@kellymercierph1) 's Twitter Profile Photo

A rapid fire update on the new data in #sclc from Taofeek K Owonikoko with data from #wclc24-both in limited stage and extensive relapse. Several opportunities to extend lives with these options. #alcs24

A rapid fire update on the new data in #sclc from <a href="/teekayowo/">Taofeek K Owonikoko</a> with data from #wclc24-both in limited stage and extensive relapse. Several opportunities to extend lives with these options. #alcs24
UMGCCC (@umgccc) 's Twitter Profile Photo

Dr. Taofeek Owonikoko (Taofeek K Owonikoko), Executive Director of UMGCCC, sat down with FOX Baltimore this morning to share ways to lower your risk for cancer. Key steps include regular screenings, staying active, and avoiding tobacco. Watch the full interview: foxbaltimore.com/fox45-mornings…

University of Maryland School of Medicine (@ummedschool) 's Twitter Profile Photo

Congrats to Dr. Taofeek K Owonikoko, Exec. Director of UMGCCC, for being named one of the 25 Black Marylanders to Watch for 2025 by The Baltimore Sun! 🏆🎉 His leadership & dedication to cancer research & patient care are truly inspiring! 🔗 bit.ly/3Xb72FI #UMGCCC #Oncology #UMSOM

Congrats to Dr. <a href="/teekayowo/">Taofeek K Owonikoko</a>, Exec. Director of <a href="/UMGCCC/">UMGCCC</a>, for being named one of the 25 Black Marylanders to Watch for 2025 by <a href="/baltimoresun/">The Baltimore Sun</a>! 🏆🎉

His leadership &amp; dedication to cancer research &amp; patient care are truly inspiring!

🔗 bit.ly/3Xb72FI
#UMGCCC #Oncology #UMSOM
UMGCCC (@umgccc) 's Twitter Profile Photo

This #CancerPreventionMonth, Dr. Shana Ntiri, Medical Director of the Baltimore City Cancer Program and Associate Prof. of Family & Community Medicine at @UmMedSchool, shares how small lifestyle changes can lower cancer risk in this @MarylandPubTV segment. youtube.com/watch?v=6sEg6f…

UMGCCC (@umgccc) 's Twitter Profile Photo

Executive Director Dr. Taofeek K. Owonikoko (Taofeek K Owonikoko) joined The Cancer Letter podcast to discuss UMGCCC's commitment to moving science and treatment forward despite uncertainty. To listen to the full podcast episode, visit: youtube.com/watch?v=TluT0e…

UMGCCC (@umgccc) 's Twitter Profile Photo

Dr. Rodney Taylor, Otorhinolaryngology Chair @UmMedSchool and ENT Surgeon University of Maryland Medical Center, spoke with WMAR-2 News about head & neck cancer, symptoms to watch for and how UMGCCC’s multidisciplinary team of experts deliver better patient outcomes. To watch, visit: wmar2news.com/middaymaryland…

Dr. Fadlo Khuri (@drfadlokhuri) 's Twitter Profile Photo

I am greatly honored to have been elected to the American Academy of Arts & Sciences. Being recognized for collaborative, mission oriented work done at American University of Beirut is especially rewarding. The opportunity to serve where I can make the greatest difference has always driven my professional decisions.

Taofeek K Owonikoko (@teekayowo) 's Twitter Profile Photo

Great interview by our patient and teammate getting ready for the Half marathon and 5K run to benefit ⁦UMGCCC⁩ nam11.safelinks.protection.outlook.com/?url=https%3A%…

DAVA Oncology (@davaonc) 's Twitter Profile Photo

Dr. Samuel Rosner (Sam Rosner from UMGCCC) presented ADRIATIC: durvalumab after CRT improved OS & PFS in LS-SCLC, establishing a new SOC. In contrast, NRG-LU005 (concurrent atezo + CRT) showed no survival benefit. IO timing may be key; biomarker research is needed. #DAVALung

Dr. Samuel Rosner (<a href="/Sam_Rosner_/">Sam Rosner</a> from <a href="/UMGCCC/">UMGCCC</a>) presented ADRIATIC: durvalumab after CRT improved OS &amp; PFS in LS-SCLC, establishing a new SOC. In contrast, NRG-LU005 (concurrent atezo + CRT) showed no survival benefit. IO timing may be key; biomarker research is needed. #DAVALung